Other disorders of pancreatic internal secretion
Notes: Functional hyperinsulinism ; Functional nonhyperinsulinemic hypoglycemia ; Hyperinsulinism NOS ; Hyperplasia of pancreatic islet beta cells NOS ; Hyperplasia of pancreatic endocrine cells with glucagon excess ; Hypergastrinemia ; Hyperplasia of pancreatic endocrine cells with gastrin excess ; Zollinger-Ellison syndrome ; Increased secretion from endocrine pancreas of growth hormone-releasing hormone ; Increased secretion from endocrine pancreas of pancreatic polypeptide ; Increased secretion from endocrine pancreas of somatostatin ; Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide ; Islet-cell hyperplasia NOS ; Pancreatic endocrine cell hyperplasia NOS ; code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) ; diabetes with hypoglycemia without coma (E09.649) ; diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649) ; hypoglycemia in infant of diabetic mother (P70.1) ; neonatal hypoglycemia (P70.4) ; diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649)